Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
A nerve injury–specific long noncoding RNA promotes neuropathic pain by increasing Ccl2 expression
Shibin Du, … , Steve Davidson, Yuan-Xiang Tao
Shibin Du, … , Steve Davidson, Yuan-Xiang Tao
Published July 1, 2022
Citation Information: J Clin Invest. 2022;132(13):e153563. https://doi.org/10.1172/JCI153563.
View: Text | PDF
Research Article Cell biology Neuroscience

A nerve injury–specific long noncoding RNA promotes neuropathic pain by increasing Ccl2 expression

  • Text
  • PDF
Abstract

Maladaptive changes of nerve injury–associated genes in dorsal root ganglia (DRGs) are critical for neuropathic pain genesis. Emerging evidence supports the role of long noncoding RNAs (lncRNAs) in regulating gene transcription. Here we identified a conserved lncRNA, named nerve injury–specific lncRNA (NIS-lncRNA) for its upregulation in injured DRGs exclusively in response to nerve injury. This upregulation was triggered by nerve injury–induced increase in DRG ELF1, a transcription factor that bound to the NIS-lncRNA promoter. Blocking this upregulation attenuated nerve injury–induced CCL2 increase in injured DRGs and nociceptive hypersensitivity during the development and maintenance periods of neuropathic pain. Mimicking NIS-lncRNA upregulation elevated CCL2 expression, increased CCL2-mediated excitability in DRG neurons, and produced neuropathic pain symptoms. Mechanistically, NIS-lncRNA recruited more binding of the RNA-interacting protein FUS to the Ccl2 promoter and augmented Ccl2 transcription in injured DRGs. Thus, NIS-lncRNA participates in neuropathic pain likely by promoting FUS-triggered DRG Ccl2 expression and may be a potential target in neuropathic pain management.

Authors

Shibin Du, Shaogen Wu, Xiaozhou Feng, Bing Wang, Shangzhou Xia, Lingli Liang, Li Zhang, Gokulapriya Govindarajalu, Alexander Bunk, Feni Kadakia, Qingxiang Mao, Xinying Guo, Hui Zhao, Tolga Berkman, Tong Liu, Hong Li, Jordan Stillman, Alex Bekker, Steve Davidson, Yuan-Xiang Tao

×

Figure 2

Upregulation of NIS V1 and V2 expression in injured DRGs of male mice after peripheral nerve injury.

Options: View larger image (or click on image) Download as PowerPoint
Upregulation of NIS V1 and V2 expression in injured DRGs of male mice af...
Data: mean ± SEM. (A–D) Levels of NIS V1 and V2 in the ipsilateral and contralateral L4 DRG, ipsilateral L3 DRG, and ipsilateral L4 spinal cord after SNL or sham surgery. n = 20 mice per time point per group. **P < 0.01, by 2-way ANOVA with post hoc Tukey’s test. (E and F) Levels of NIS V1 and V2 in the ipsilateral and contralateral L3/4 DRGs after CCI or sham surgery. n = 10 mice per time point per group. *P < 0.05, **P < 0.01, by 2-way ANOVA with post hoc Tukey’s test. (G–I) Levels of NIS V1 and V2 in the ipsilateral L3/4 DRGs after unilateral hind-paw injection of complete Freund’s adjuvant (CFA), after unilateral intra-articular injection of sodium monoiodoacetate (MIA), or after unilateral hind-paw incision. n = 10 mice per time point per group. One-way ANOVA with post hoc Tukey’s test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts